Equities

Lipidor AB

Lipidor AB

Actions
  • Price (SEK)5.90
  • Today's Change-0.01 / -0.17%
  • Shares traded12.06k
  • 1 Year change-61.18%
  • Beta--
Data delayed at least 15 minutes, as of Jun 23 2022 17:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Lipidor AB is a Sweden-based drug delivery company focusing on topical medication. The Company is focused to develop, patent and commercialize formulation concepts and technologies based on lipids. The Company develops product concepts based on AKVANO technology, which represents a dosage form that creates a lipid layer on the skin surface for effective delivery of drugs and skin care treatment. The Company’s cooperation partners include Cerbios-Pharma, which specializes in the development and manufacturing of chemical and biological active pharmaceutical ingredients (APIs), and Aurena Laboratories AB, a manufacturer of bag-on-valve aerosol sprays for the pharmaceutical and medical device industry.

  • Revenue in SEK (TTM)15.27m
  • Net income in SEK-27.13m
  • Incorporated--
  • Employees--
  • Location
    Lipidor ABKarolinska Institutet Science ParkFogdevreten 2SOLNA 171 65SwedenSWE
  • Websitehttp://www.lipidor.se/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sprint Bioscience AB35.12m-25.59m125.31m28.00--2.23--3.57-0.8986-0.89861.111.410.858--10.39---62.51-76.29-98.43-137.1966.1466.67-72.86-103.55----0.00--107.960.069641.38---22.86--
Annexin Pharmaceuticals AB (publ)0.00-42.53m126.22m4.00--3.27-----0.4714-0.47140.000.27160.00-------160.59-118.13-218.89-143.44-----------45.790.00-------17.86------
PCI Biotech Holding ASA6.04m-90.10m153.13m17.00--1.68--25.36-2.35-2.350.15732.380.0397--0.4125345,470.60-59.27-33.17-67.76-36.55-----1,492.07-762.80----0.0193---14.86-9.75-22.36------
Combigene AB95.44m29.14m159.80m--5.901.035.041.671.371.375.037.860.8246--6.24--25.17-19.2926.96-24.55----30.53-55.8520.35--0.00------171.35------
Aqua Bio Technology ASA799.90k-18.19m166.44m2.00--10.68--208.07-0.9844-0.98440.04330.74260.04720.62480.4401---107.32-42.18-184.80-51.66-79.99-72.16-2,274.58-2,362.501.05-35.650.3348---50.152.97-11.26---41.51--
Coegin Pharma AB0.00-22.20m167.32m----4.11-----0.0335-0.03350.000.05860.00-------59.01---71.92--------------0.00------44.10------
Lipidor AB15.27m-27.13m167.54m----5.27--10.97-0.9441-0.94410.5341.120.2993--238.63---53.16---59.19-------177.64------0.00--2,380.00---31.39------
Lumito AB (publ)0.00-25.98m171.75m----1.62-----0.2274-0.22740.000.67760.00-------25.17-21.69-26.86-23.38------------0.00-------64.34------
StenoCare A/S3.40m-19.56m171.86m----3.20--50.52-1.19-1.190.2073.200.0481--2.25---27.66---29.25-------574.87--9.92-103.870.1619--854.55---8.03------
Saniona AB13.67m-460.87m177.49m56.00--1.07--12.99-7.39-7.390.2192.660.0281--2.69278,877.60-94.80-54.80-110.12-66.36-1,913.07-447.87-3,372.64-634.11---33.640.3729--27.81-32.53-459.58--12.71--
New Nordic Healthbrands AB510.35m11.90m184.13m37.0015.361.5014.280.36081.921.9282.3819.692.134.184.43--4.9713.059.5625.3614.8817.562.335.290.957631.170.189238.8714.3910.9819.9217.3535.3325.59
Moberg Pharma AB (publ)0.00-15.59m185.71m----0.1992-----0.3417-0.34170.009.350.00-------3.43---3.54-------------109.050.0074--------------
Bactiquant A/S12.02m-19.48m190.40m----6.29--15.84-0.7601-0.76010.46441.140.45134.827.88---73.17-9.71-81.53-11.11-35.35---162.12-22.385.28-16.810.0472--52.48---1,117.49------
Intellego Technologies AB8.23m-5.67m202.00m----14.46--24.54-0.3124-0.31240.47930.71240.79830.23365.01---55.00---64.01--96.27---68.89--4.57-93.030.0376--22.70---220.86------
Klaria Pharma Holding AB (publ)0.00-90.50m207.50m----3.18-----1.73-1.730.001.210.00-------68.54-29.15-90.82-33.67-------2,713.74---23.240.00-------4.07------
Targovax ASA0.00-108.91m211.22m19.00--0.5371-----0.8649-0.86490.002.030.00----0.00-21.19-23.02-22.52-24.83-------21,183.60---23.700.1309---100.00--9.39------
Data as of Jun 23 2022. Currency figures normalised to Lipidor AB's reporting currency: Swedish Krona SEK
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.